Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by Journeytcon Nov 06, 2024 7:50pm
113 Views
Post# 36300011

Election

ElectionWhether right or left I hope we can agree the medical system is broken and pharma and regulatory bodies no longer subscribe to improving health.  Its about supporting narratives, political objectives and profit. People and agencies we depend on sold their souls. 

I think ONC has been victim in this.   And activating MAHA is long overdue.  Kennedy describes meeting held in i think 2010 with attendance of all major pharmaceutical heads and leadership of FDA, CDC and NIH.   A two day meeting to review analysis of data regarding vaccines and actions to be taken.  First day discussing black swan findings, and second day to decide how to cover up.   Kennedy knows as someone provided him meeting minutes.

I think pela is a century race horse and a threat.  It is a solution that threatens pharma profitability and threatens royalties the FDA and NIH collect and distribute to staff.

Trumps election and Kennedys appointment are critical to wiping out medical corruption and evil.  And i think that can only bode well for ONC.  
 
<< Previous
Bullboard Posts
Next >>